Related Experiment Videos

Antibody testing in Lyme disease. A comparison of results in four laboratories

B S Schwartz1, M D Goldstein, J M Ribeiro

  • 1Section of General Internal Medicine, University of Pennsylvania, Philadelphia.

JAMA
|December 22, 1989
PubMed

Insights

Lyme disease serological testing shows low agreement between laboratories. Standardizing these tests is crucial for reliable Lyme disease diagnosis and patient care.

Area of Science:

  • Infectious Diseases
  • Medical Diagnostics
  • Public Health

Background:

  • Lyme disease is a significant public health concern, particularly in outdoor worker populations.
  • Accurate serological testing is essential for diagnosing Lyme disease.
  • Variability in testing performance can impact diagnostic accuracy and patient management.

Purpose of the Study:

  • To assess the interlaboratory and intralaboratory agreement of Lyme disease serological tests.
  • To identify potential inconsistencies in Lyme disease diagnostic testing across different laboratory settings.

Main Methods:

  • Serum specimens from 132 outdoor workers in New Jersey were distributed to four independent laboratories.
  • Testing included a state health department, a commercial laboratory, and two research laboratories.
  • The kappa statistic was used to measure agreement in test performance.

Main Results:

  • Interlaboratory agreement, measured by the kappa statistic, ranged from 0.45 to 0.53.
  • Intralaboratory agreement within the commercial laboratory ranged from 0.50 to 0.54.
  • These kappa values indicate low levels of agreement in Lyme disease serological testing.

Conclusions:

  • Current Lyme disease serological testing procedures exhibit low interlaboratory and intralaboratory agreement.
  • Standardization of Lyme disease serological testing is recommended to improve comparability of results.
  • Improved standardization is necessary for reliable diagnosis and management of Lyme disease.

Related Concept Videos